PTPRC and neoplasm: From visualizing our FACs data, we observed that the decrease in live tumor cells in the presence of the ADU-S100 and IL-15 combination was not due to a lack of proliferation of the tumor cells as we observed a clear reduction of live CD45 negative cells (Figure 1 and Supplementary Figure 1) and an increase in dead cells.